http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13571610

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Observational Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 772
issn 1875-8908
1387-2877
issueIdentifier 2
pageRange 769-772
publicationName Journal of Alzheimer's disease : JAD
startingPage 769
bibliographicCitation Takemoto M, Ohta Y, Hishikawa N, Yamashita T, Nomura E, Tsunoda K, Sasaki R, Tadokoro K, Matsumoto N, Omote Y, Abe K. The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP). J Alzheimers Dis. 2020;76(2):769–72. doi: 10.3233/jad-200247. PMID: 32568205.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caa4011ec973a7f9a5f4e6105e3ede13
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a327a9edd5d7bae7d28be6d4babf9e9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3d27376e97ebe9f4d4ecb715c8fd62d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97354d43de8bda4c381624d3300dc975
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0baa14e2bd17567208798f631e299ec3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63de5401be6cd1fefaec32f52e060ca6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f171786037366d9d3c891d4934b2165
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9552063035c3c8c18f186b609400c25e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6e20b4c969c7a5b94c7f773645a2561
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c92a8e9e4201a3ddf481b1ccba84d642
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73d2cfc9839a2a9a5f8041140ec25887
date 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3233/jad-200247
https://pubmed.ncbi.nlm.nih.gov/32568205
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer’s Disease: The Okayama Depression and Apathy Project (ODAP)
discusses http://id.nlm.nih.gov/mesh/M0028009
http://id.nlm.nih.gov/mesh/M0001384
http://id.nlm.nih.gov/mesh/M0014823
http://id.nlm.nih.gov/mesh/M0023529
http://id.nlm.nih.gov/mesh/M0029930
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020280Q000627
http://id.nlm.nih.gov/mesh/D000544Q000188
http://id.nlm.nih.gov/mesh/D015283Q000627
http://id.nlm.nih.gov/mesh/D009530Q000627
http://id.nlm.nih.gov/mesh/D057565Q000187
http://id.nlm.nih.gov/mesh/D003863Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009530Q000494
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D016037
http://id.nlm.nih.gov/mesh/D000544Q000523
http://id.nlm.nih.gov/mesh/D020280Q000494
http://id.nlm.nih.gov/mesh/D015283Q000494
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D000544Q000175
http://id.nlm.nih.gov/mesh/D057565Q000502
http://id.nlm.nih.gov/mesh/D000928Q000627
http://id.nlm.nih.gov/mesh/D018697Q000627
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003863Q000523
http://id.nlm.nih.gov/mesh/D003863Q000175
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34040
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617

Total number of triples: 66.